Suchergebnisse
Suchergebnisse:
INFINITY PHARMACEUTICALS AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Infinity Pharmaceuticals IncShs | A0LA4Y | INFIQ | US45665G3039
INFIQ | Infinity Pharmaceuticals Aktien News ☑ Mit Realtime Kurs, Dividende und Prognose der Infinity Pharmaceuticals Aktie Analysiere mit wallstreetONLINE.
24. Juli 2023 · Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potential first-in-class, oral, immuno-oncology macrophage...
Infinity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel medicines for people with cancer. The company's product candidate, including eganelisib (IPI-549), an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in ...
Realtime Aktienkurs der INFINITY PHARMACEUTICALS Aktie mit Live-Chart inkl. Kursentwicklung, News & Analysen. Aktueller Aktienwert heute inkl. Aktienverlauf & Wertentwicklung.
14. Juli 2023 · Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potential first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which is designed to address a fundamental biologic mechanism of immune suppression in cancer in multiple clinical studies.
28. März 2023 · The Company previously announced on February 23, 2023 its execution of a definitive merger agreement with MEI Pharma for a strategic combination of Infinity and MEI, which is expected to close in ...